We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.86%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$33.5B
AUM Growth
+$3.49B
(+12%)
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
6.76%
Top 10 Holdings %
Top 10 Hldgs %
5.56%
Holding
3,907
New
829
Increased
1,295
Reduced
1,108
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.03% |
| 2 | Consumer Discretionary | 10.89% |
| 3 | Industrials | 10.39% |
| 4 | Healthcare | 9.44% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
| $8.18M | 0.02% |
23,700
-1,300
| -5% | -$407K |
|
752
Boot Barn
BOOT
$4.51B
| $8.17M | 0.02% |
393,925
+37,122
| +10% | +$783K |
|
753
Synaptics
SYNA
$4.19B
| $8.16M | 0.02% |
162,084
-97,572
| -38% | -$4.43M |
|
754
PTC Therapeutics
PTCT
$5.68B
| $8.15M | 0.02% |
241,541
-416,113
| -63% | -$13M |
|
755
PUT
Apple
AAPL
$4.54T
| $8.14M | 0.02% |
176,000
+160,000
| +1,000% | +$7.26M |
|
756
Sabra Healthcare REIT
SBRA
$5.34B
| $8.14M | 0.02% |
374,811
+244,279
| +187% | +$4.77M |
|
|
GPT
757
DELISTED
Gramercy Property Trust
GPT
| $8.14M | 0.02% |
298,115
-541,185
| -64% | -$13.9M |
|
758
Conduent
CNDT
$244M
| $8.14M | 0.02% |
448,103
-2,173,482
| -83% | -$42M |
|
759
Tesla
TSLA
$1.23T
| $8.11M | 0.02% |
+354,750
| New | +$7.21M |
|
760
Leidos
LDOS
$14.5B
| $8.11M | 0.02% |
137,366
-67,781
| -33% | -$4.23M |
|
761
PUT
FirstEnergy
FE
$28B
| $8.09M | 0.02% |
225,400
-27,000
| -11% | -$925K |
|
762
Vishay Intertechnology
VSH
$5.25B
| $8.08M | 0.02% |
348,239
+311,699
| +853% | +$6.5M |
|
763
IQVIA
IQV
$38.7B
| $8.07M | 0.02% |
80,842
+4,025
| +5% | +$402K |
|
764
Dolby
DLB
$5.51B
| $8.06M | 0.02% |
130,664
-112,270
| -46% | -$7.14M |
|
765
CALL
Eli Lilly
LLY
$1.02T
| $8.01M | 0.02% |
93,900
+63,100
| +205% | +$5.18M |
|
|
AVTA
766
DELISTED
Avantax, Inc. Common Stock
AVTA
| $8.01M | 0.02% |
+216,397
| New | +$6.98M |
|
|
CATM
767
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $8M | 0.02% |
330,887
+87,457
| +36% | +$2.27M |
|
768
Royal Gold
RGLD
$16.8B
| $7.99M | 0.02% |
86,107
-35,824
| -29% | -$3.21M |
|
769
CALL
Bristol-Myers Squibb
BMY
$133B
| $7.97M | 0.02% |
144,100
+78,700
| +120% | +$4.25M |
|
770
CALL
Emerson Electric
EMR
$83.9B
| $7.96M | 0.02% |
115,200
+83,200
| +260% | +$5.85M |
|
771
Aptiv
APTV
$12B
| $7.96M | 0.02% |
86,834
-26,400
| -23% | -$2.46M |
|
772
CALL
FedEx
FDX
$72.7B
| $7.95M | 0.02% |
35,000
-5,600
| -14% | -$1.39M |
|
773
Sun Communities
SUI
$15.2B
| $7.93M | 0.02% |
81,060
+39,913
| +97% | +$3.75M |
|
774
Trimble
TRMB
$13.2B
| $7.91M | 0.02% |
+240,890
| New | +$8.36M |
|
775
Insight Enterprises
NSIT
$3.89B
| $7.9M | 0.02% |
161,545
+153,157
| +1,826% | +$6.59M |
|
Similar funds
VAM
Two Sigma Investments's Q2 2018 Portfolio in Review
As of Q2 2018, Two Sigma Investments held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
Two Sigma Investments deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- Two Sigma Investments's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- Two Sigma Investments added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- Two Sigma Investments's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- Two Sigma Investments fully exited Pfizer in Q2 2018, selling an estimated $159M.
- Two Sigma Investments's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- Two Sigma Investments opened 829 new positions and closed 662 in Q2 2018.
- Two Sigma Investments's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.